C.H. Robinson - RXO Is No Shortcut To Value, I Say 'No' (NASDAQ:CHRW)
· seekingalpha.com
C.H. Robinson's $5.8B RXO acquisition sparks a selloff; assess deal risk, 42x EBITDA valuation, synergy realism, and the $90 Hold target. Click for more on CHRW stock.
It seems to me that plenty of companies are looking at M&A's that, overall, might not be the overall best ideas for their business - at least not if we're to go...